Overview Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia Status: Active, not recruiting Trial end date: 2021-09-01 Target enrollment: Participant gender: Summary The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia Phase: Phase 2 Details Lead Sponsor: Ocuphire Pharma, Inc.Treatments: Ophthalmic SolutionsPharmaceutical SolutionsPhentolaminePilocarpine